Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NEPH stock hub

Nephros, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NEPHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NEPH

In the news

Latest news · NEPH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E50.3

P25 12.3P50 18.4P75 33.1

Trailing P/E49.6

P25 14.9P50 23.2P75 38.5

ROE7.8

P25 -105.6P50 -46.5P75 -3.1

ROIC9.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NEPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001196298
Company name	Nephros, Inc.
Country	United States
Country code	US
Cusip	640671400
Employees	36
Employees Change	5%
Employees Change Percent	16.13
Enterprise value	$34.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2004-09-21
Isin	US6406714005
Last refreshed	2026-05-10
Market cap	$37.5M
Market cap category	Nano-Cap
Price	$3.52
Price currency	USD
Rev Per Employee	531,222.22x
Sector	Healthcare
Sic	3841
Symbol	NEPH
Website	https://www.nephros.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.07%
EV Earnings	44.35x
EV Sales Forward	1.64x
EV/EBIT	50.84x
EV/EBITDA	42.86x
EV/Sales	1.8x
FCF yield	-0.93%
Forward P/E	50.29x
P/B ratio	3.57x
P/E ratio	49.56x
P/S ratio	1.96x
PS Forward	1.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.54%
EBITDA Margin	4.2%
Gross margin	59.95%
Gross Profit	$11.5M
Gross Profit Growth	18.31%
Gross Profit Growth Q	-5.1%
Gross Profit Growth3 Y	25.58%
Gross Profit Growth5 Y	18.01%
Net Income	$776,000
Net Income Growth	-3.12%
Net Income Growth Q	-74.91%
Net Income Growth Years	3%
Pretax Margin	4.12%
Profit Margin	4.06%
Profit Per Employee	$21,556
Profitable Years	2
ROA	3.31
Roa5y	-6.61
ROCE	6.01
ROE	7.76
Roe5y	-11.85
ROIC	9.87
Roic5y	-20.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.19%
Cagr15y	-2.25%
Cagr1y	80.6%
Cagr20y	-20.85%
Cagr3y	34.7%
Cagr5y	-13.78%
EPS Growth	-6.46
EPS Growth Q	-80
EPS Growth Years	3
Revenue Growth	23.25x
Revenue Growth Q	6.87x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	18.43x
Revenue Growth5 Y	16.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.5
Assets	$13.8M
Cash	$4M
Current Assets	$11.5M
Current Liabilities	$2.5M
Debt	$968,000
Debt EBITDA	$0.77
Debt Equity	$0.09
Equity	$10.7M
Interest Coverage	677
Liabilities	$3.1M
Long Term Assets	$2.3M
Long Term Liabilities	$566,000
Net Cash	$3.1M
Net Cash By Market Cap	$8.14
Net Cash Growth	10.75%
Net Debt EBITDA	$-3.8
Net Debt Equity	$-0.29
Tangible Book Value	$9.5M
Tangible Book Value Per Share	$0.87
WACC	12.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.55
Inventory Turnover	2.75
Net Working Capital	$5.4M
Quick ratio	2.98
Working Capital	$9M
Working Capital Turnover	$2.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.06%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	24.16%
1Y total return	80.52%
200-day SMA	4.22
3Y total return	144.44%
50-day SMA	3.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-52.36%
All Time High	1,128.6
All Time High Change	-99.69%
All Time High Date	2004-09-28
All Time Low	0.9
All Time Low Change	291.11%
All Time Low Date	2011-03-23
ATR	0.28
Beta	1.47
Beta1y	0.08
Beta2y	-0.47
Ch YTD	-27.87
High	3.78
High52	6.42
High52 Date	2025-11-26
High52ch	-45.17%
Low	2.91
Low52	1.88
Low52 Date	2025-05-09
Low52ch	87.73%
Ma50ch	9.86%
Price vs 200-day SMA	-16.59%
RSI	64.33
RSI Monthly	51.96
RSI Weekly	46.25
Sharpe ratio	1.02x
Sortino ratio	1.96
Total Return	-4.06%
Tr YTD	-27.87
Tr15y	-28.89%
Tr1m	26.62%
Tr1w	13.18%
Tr3m	-9.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$0.01
Earnings EPS Estimate Growth	-80
Earnings Revenue Estimate	4,993,000x
Earnings Revenue Estimate Growth	2.38x
Operating Income	$677,000
Operating Income Growth	-12.31
Operating Income Growth Q	-82.86
Operating margin	3.54
Price target	$6
Price Target Change	$70.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,581,553%
Float Percent	80.62%
Net Borrowing	-5,000
Shares Insiders	13.61%
Shares Institutions	43.94%
Shares Out	10,644,268
Shares Qo Q	-1.91%
Shares Yo Y	4.06%
Short Float	0.48%
Short Ratio	0.96
Short Shares	0.39

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-628,000
Average Volume	25,602.55x
Bv Per Share	0.99
Ch10y	24.16
Ch15y	-28.89
Ch1m	26.62
Ch1w	13.18
Ch1y	80.51
Ch20y	-99.07
Ch3m	-9.04
Ch3y	144.4
Ch5y	-52.36
Ch6m	-23.48
Change	8.98%
Change From Open	13.92
Close	3.23
Days Gap	-4.33
Depreciation Amortization	126,000
Dollar Volume	440,897.6
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$677,000
EBITDA	$803,000
EPS	$0.07
F Score	3
FCF	$-348,000
FCF EV Yield	-1.01x
FCF Per Share	$-0.03
Financing CF	285,000
Fiscal Year End	December
Founded	1,997
Goodwill	759,000
Graham Number	1.25576
Graham Upside	-64.33
Income Tax	$12,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2019-07-10
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	4.29
Ma150ch	-17.89%
Ma20	3.08
Ma20ch	14.43%
Net CF	-63,000
Next Earnings Date	2026-08-06
Open	3.09
Optionable	No
Position In Range	70.11
Post Close	3.52
Postmarket Change Percent	-1.49
Postmarket Price	$3.47
Ppne	1,023,000
Price Date	2026-05-08
Price EBITDA	$46.66
Ptbv Ratio	3.95
Relative Volume	4.89x
Revenue	19,124,000x
SBC By Revenue	1.46x
Share Based Comp	280,000
Tax By Revenue	0.06x
Tax Rate	1.52%
Tr20y	-99.07%
Tr6m	-23.48%
Us State	New Jersey
Volume	125,255

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NEPH pay a dividend?

Capital-return profile for this ticker.

Performance

NEPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NEPH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.9%

Float: +80.6% of shares outstanding

Insider ownership

+13.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NEPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.3

Neutral momentum band

Price vs 200-day MA

-16.6%

50/200-day relationship not available

Beta (5Y)

1.47

More volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NEPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NEPH stock rating?

Nephros, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NEPH analysis?

The full report lives at /stocks/NEPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NEPH?

The latest report frames NEPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NEPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.